Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations.

Letourneau LR, Greeley SAW.

Curr Diab Rep. 2019 Jun 27;19(8):52. doi: 10.1007/s11892-019-1175-9. Review.

PMID:
31250216
2.

Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).

Gregory JM, Smith TJ, Slaughter JC, Mason HR, Hughey CC, Smith MS, Kandasamy B, Greeley SAW, Philipson LH, Naylor RN, Letourneau LR, Abumrad NN, Cherrington AD, Moore DJ.

Diabetes. 2019 Aug;68(8):1565-1576. doi: 10.2337/db19-0324. Epub 2019 May 15.

PMID:
31092478
3.

Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated.

Johnson MB, De Franco E, Greeley SAW, Letourneau LR, Gillespie KM; International DS-PNDM Consortium, Wakeling MN, Ellard S, Flanagan SE, Patel KA, Hattersley AT.

Diabetes. 2019 Jul;68(7):1528-1535. doi: 10.2337/db19-0045. Epub 2019 Apr 8.

PMID:
30962220
4.

Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry.

Dickens LT, Letourneau LR, Sanyoura M, Greeley SAW, Philipson LH, Naylor RN.

Acta Diabetol. 2019 Apr;56(4):405-411. doi: 10.1007/s00592-018-1267-z. Epub 2018 Dec 11.

PMID:
30535721
5.

Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features.

Letourneau LR, Greeley SAW.

Curr Diab Rep. 2018 Jun 13;18(7):46. doi: 10.1007/s11892-018-1016-2. Review.

6.

Precision medicine in KCNJ11 permanent neonatal diabetes.

Greeley SAW, Letourneau LR, Philipson LH.

Lancet Diabetes Endocrinol. 2018 Aug;6(8):594-595. doi: 10.1016/S2213-8587(18)30138-4. Epub 2018 Jun 4. No abstract available.

7.

Monogenic diabetes: the impact of making the right diagnosis.

Harris AG, Letourneau LR, Greeley SAW.

Curr Opin Pediatr. 2018 Aug;30(4):558-567. doi: 10.1097/MOP.0000000000000643. Review.

8.

Congenital forms of diabetes: the beta-cell and beyond.

Letourneau LR, Greeley SAW.

Curr Opin Genet Dev. 2018 Jun;50:25-34. doi: 10.1016/j.gde.2018.01.005. Epub 2018 Feb 16. Review.

9.

Early Intensive Insulin Use May Preserve β-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene.

Letourneau LR, Carmody D, Philipson LH, Greeley SAW.

J Endocr Soc. 2017 Nov 24;2(1):1-8. doi: 10.1210/js.2017-00356. eCollection 2018 Jan 1.

10.

Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.

Lanning MS, Carmody D, Szczerbiński Ł, Letourneau LR, Naylor RN, Greeley SAW.

Pediatr Diabetes. 2018 May;19(3):393-397. doi: 10.1111/pedi.12599. Epub 2017 Dec 5.

11.

Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis.

Letourneau LR, Carmody D, Wroblewski K, Denson AM, Sanyoura M, Naylor RN, Philipson LH, Greeley SAW.

Diabetes Care. 2017 Oct;40(10):e147-e148. doi: 10.2337/dc17-1145. Epub 2017 Aug 4. No abstract available.

12.

Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls.

Carmody D, Pastore AN, Landmeier KA, Letourneau LR, Martin R, Hwang JL, Naylor RN, Hunter SJ, Msall ME, Philipson LH, Scott MN, Greeley SA.

Diabet Med. 2016 Oct;33(10):1380-6. doi: 10.1111/dme.13159. Epub 2016 Jun 22.

Supplemental Content

Loading ...
Support Center